The Clinical Added Value of Breast Cancer Imaging Using Hybrid PET/MR Imaging.

Journal: Magnetic resonance imaging clinics of North America
Published Date:

Abstract

Dedicated MR imaging is highly performant for the evaluation of the primary lesion and should regularly be added to whole-body PET/MR imaging for the initial staging. PET/MR imaging is highly sensitive for the detection of nodal involvement and could be combined with the high specificity of axillary second look ultrasound for the confirmation of the N staging. For M staging, with the exception of lung lesions, PET/MR imaging is superior to PET/computed tomography, at half the radiation dose. The predictive value of multiparametric imaging with PET/MR imaging holds promise to improve through radiomics and artificial intelligence.

Authors

  • Ismini C Mainta
    Department of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland. Electronic address: isminicharis.mainta@hcuge.ch.
  • Ilektra Sfakianaki
    Department of Radiology, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland.
  • Isaac Shiri
    Biomedical and Health Informatics, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Diomidis Botsikas
    Department of Radiology, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland.
  • Valentina Garibotto
    Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.